dehydroepiandrosterone sulfate has been researched along with Carcinoma in Situ in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baffico, M; Cappi, C; De Cassan, P; Foppiani, L; Giusti, M; Lando, G; Minuto, F; Patrosso, MC; Penco, S; Vitali, A | 1 |
Carruth, JA; Colquhoun-Flannery, W | 1 |
2 other study(ies) available for dehydroepiandrosterone sulfate and Carcinoma in Situ
Article | Year |
---|---|
Bilateral carcinoma in situ of the testis and cystic fibrosis transmembrane conductance regulator (CFTR) mutation in an azoospermic patient with late-onset 21beta-hydroxylase deficiency.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Hyperplasia, Congenital; Adult; Carcinoma in Situ; Cystic Fibrosis Transmembrane Conductance Regulator; Dehydroepiandrosterone Sulfate; Dexamethasone; Follicle Stimulating Hormone; Glucocorticoids; Humans; Male; Mutation; Obesity; Oligospermia; Steroid 21-Hydroxylase; Testicular Neoplasms; Testosterone; Vas Deferens | 2004 |
Low adrenal androgen output in patients with abnormal laryngeal epithelium.
Topics: Aged; Biomarkers, Tumor; Biopsy; Carcinoma in Situ; Dehydroepiandrosterone Sulfate; Humans; Laryngeal Neoplasms; Laryngitis; Luteinizing Hormone; Male; Pilot Projects; Testosterone; Vocal Cords | 1996 |